2nd Quarter - Report
THE UNITED STATES PHARMACOPEIAL CONVENTION for THE UNITED STATES PHARMACOPEIAL CONVENTION
Income
—
Expenses
$70,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment and supply chain shortages. National Defense Authorization Act; Labor, Health and Human Services and related agencies Appropriations: Provisions related to pharmaceutical supply chain and quality. Issues related to drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M. HILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.